NasdaqCM - Nasdaq Real Time Price USD

Nexalin Technology, Inc. (NXL)

Compare
3.9600 -0.2000 (-4.81%)
At close: December 13 at 4:00:01 PM EST
4.0500 +0.09 (+2.27%)
After hours: December 13 at 7:55:43 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NXL

Recent News: NXL

View More
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market
GlobeNewswire 19 days ago
Nexalin Technology CEO Provides Letter to Shareholders

Nexalin Technology CEO Provides Letter to Shareholders
GlobeNewswire last month
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth?

Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth?
Simply Wall St. last month
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
GlobeNewswire last month
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
GlobeNewswire last month
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESSWIRE last month
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease
GlobeNewswire last month
EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients (UPDATED)

EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients (UPDATED)
Benzinga last month
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESSWIRE last month
Nexalin trials Halo neurostimulation device in traumatic brain injury

Nexalin trials Halo neurostimulation device in traumatic brain injury
Clinical Trials Arena last month
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
GlobeNewswire last month
View More

Related Tickers

CLPT ClearPoint Neuro, Inc.
15.33
-6.55%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
1.1700
-2.09%
 
MDAI Spectral AI, Inc.
1.8000
-10.89%
 
QSI Quantum-Si incorporated
1.7200
-4.97%
 
SINT Sintx Technologies, Inc.
3.1000
-4.62%
 
BJDX Bluejay Diagnostics, Inc.
4.6300
+0.65%
 
NAOV NanoVibronix, Inc.
0.6148
+0.79%
 
SMLR Semler Scientific, Inc.
67.17
-6.50%
 
TMDX TransMedics Group, Inc.
64.26
-2.21%
 
TRIB Trinity Biotech plc
0.9050
+0.67%